Compounds > nad
Page last updated: 2024-08-17

nad and Lung Diseases

nad has been researched along with Lung Diseases in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19904 (57.14)18.7374
1990's1 (14.29)18.2507
2000's1 (14.29)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cabellos-Avelar, T; Calderón-Torres, CM; Chirino, YI; Delgado-Buenrostro, NL; Freyre-Fonseca, V; García-Cuéllar, CM; Gutiérrez-Cirlos, EB; Molina-Jijón, E; Pedraza-Chaverri, J; Pinzón, E; Sánchez-Pérez, Y; Torres, I; Zazueta, C1
Carlson, GP1
Wasserman, K1
Britigan, BE; Cox, CD; Railsback, MA1
Díaz Pérez, A; González Azpeitia, J; Nuño Lopez, J; Pereda, JM; Romero López, J; Sanchidrian, P1
Robin, ED; Theodore, J1
Dube, V; Hunter, DT; Knight, JA1

Reviews

1 review(s) available for nad and Lung Diseases

ArticleYear
Extrapulmonary manifestations of respiratory disease with emphasis on abnormal electron (redox) metabolism.
    The Medical clinics of North America, 1973, Volume: 57, Issue:3

    Topics: Acidosis; Animals; Brain; Diabetes Mellitus, Experimental; Diabetic Ketoacidosis; Electron Transport; Erythrocytes; Humans; Hypercapnia; Hypoxia; Liver; Lung Diseases; Macrophages; NAD; NADP; Nitrogen Dioxide; Oxidation-Reduction; Pulmonary Alveoli; Starvation

1973

Other Studies

6 other study(ies) available for nad and Lung Diseases

ArticleYear
Titanium dioxide nanoparticles impair lung mitochondrial function.
    Toxicology letters, 2011, Apr-25, Volume: 202, Issue:2

    Topics: Animals; Dose-Response Relationship, Drug; Lung Diseases; Membrane Potential, Mitochondrial; Microscopy, Confocal; Microscopy, Interference; Mitochondria; NAD; Nanoparticles; Oxygen Consumption; Rats; Rats, Wistar; Reactive Oxygen Species; Titanium

2011
Effect of the inhibition of the metabolism of 4-vinylphenol on its hepatotoxicity and pneumotoxicity in rats and mice.
    Toxicology, 2002, Sep-30, Volume: 179, Issue:1-2

    Topics: Alkynes; Animals; Antidotes; Benzene Derivatives; Bronchoalveolar Lavage Fluid; Cell Count; Chemical and Drug Induced Liver Injury; Ditiocarb; Enzyme Inhibitors; Injections, Intraperitoneal; L-Lactate Dehydrogenase; Lung Diseases; Male; Mice; Mice, Inbred ICR; NAD; Phenols; Rats; Rats, Sprague-Dawley; Succinate Dehydrogenase

2002
The anaerobic threshold measurement to evaluate exercise performance.
    The American review of respiratory disease, 1984, Volume: 129, Issue:2 Pt 2

    Topics: Acidosis; Adult; Anaerobiosis; Bicarbonates; Carbon Dioxide; Cardiovascular Diseases; Exercise Test; Humans; Lactates; Lung Diseases; Male; Mitochondria, Muscle; NAD; Oxygen; Oxygen Consumption; Physical Exertion; Pulmonary Gas Exchange

1984
The Pseudomonas aeruginosa secretory product pyocyanin inactivates alpha1 protease inhibitor: implications for the pathogenesis of cystic fibrosis lung disease.
    Infection and immunity, 1999, Volume: 67, Issue:3

    Topics: alpha 1-Antitrypsin; Cystic Fibrosis; Humans; Lung Diseases; NAD; Oxidation-Reduction; Pseudomonas aeruginosa; Pyocyanine; Reactive Oxygen Species; Superoxides; Tumor Cells, Cultured

1999
[Study of sputum by using the SMA 12/60. Preliminary observations].
    Revista clinica espanola, 1977, Sep-15, Volume: 146, Issue:5

    Topics: Autoanalysis; Humans; L-Lactate Dehydrogenase; Lung Diseases; Lung Neoplasms; NAD; Sputum

1977
Automated spectrophotometric assay of serum lactic dehydrogenase and hydroxybutyric dehydrogenase with clinical evaluation.
    American journal of clinical pathology, 1968, Volume: 50, Issue:4

    Topics: Automation; Heart Diseases; Humans; Hydroxybutyrate Dehydrogenase; Keto Acids; L-Lactate Dehydrogenase; Lung Diseases; Methods; Muscular Diseases; NAD; NADP; Pyruvates; Spectrophotometry

1968